Previous studies demonstrated that IDH1 mutations frequently occurred in grade II and III gliomas and secondary GBM glioblastoma, but rarely in primary GBM [9]; whereas IDH2 mutations occur in fewer than 3% of glial tumors. The gene discussed is IDH2; the disease is glioma.